Elaine Yang - 07 Dec 2021 Form 4 Insider Report for Zosano Pharma Corp

Role
Director
Signature
/s/ Christine Matthews, Attorney-in-fact for Elaine Yang
Issuer symbol
N/A
Transactions as of
07 Dec 2021
Net transactions value
$0
Form type
4
Filing time
09 Dec 2021, 17:35:28 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZSAN Stock Option (Right to Buy) Award $0 +90,000 $0.000000 90,000 07 Dec 2021 Common Stock 90,000 $0.5580 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to 25% of the total number of the underlying shares on December 7, 2022, and the remaining shares will vest in equal monthly installments over the following three-year period such that the stock option will be fully vested on December 7, 2025